Marquette Asset Management »

Bolt Biotherapeutics shares owned by Marquette Asset Management

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Marquette Asset Management from 13F filings

Historical chart of Marquette Asset Management investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Marquette Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Marquette Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $108k 97k 1.12
2023-09-30 $102k 98k 1.04
2023-06-30 $125k 98k 1.28
2023-03-31 $136k 98k 1.39
2022-12-31 $127k 98k 1.30
2022-09-30 $94k 64k 1.47
2022-06-30 $130k 64k 2.04

More positions owned by Marquette Asset Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Schwab Strategic Tr Us Dividend Eq (SCHD)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core Us Aggbd Et (AGG)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Ser Tr S&p Kensho New (KOMP)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Rus 1000 Val Etf (IWD)
First Tr Dow Jones Select Mi Com Shs Annual (FDM)

View all positions for Marquette Asset Management

Top funds holding Bolt Biotherapeutics

Tang Capital Management
Vivo Capital
Citadel Advisors
Newtyn Management
OrbiMed Advisors
Samsara BioCapital
Vanguard Group
Board of Trustees of The Leland Stanford Junior University
Acuitas Investments
Marquette Asset Management
Squarepoint Ops
Two Sigma Securities
Jane Street
Millennium Management
UBS Group

View all funds holding Bolt Biotherapeutics